Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NanoViricides (NNVC)
NYSE MKT:NNVC
Holding NNVC?
Track your performance easily
NNVC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.00 - $3.59
Previous Close$1.36
Volume309.02K
Average Volume (3M)202.26K
Market Cap
$18.97M
Enterprise Value$14.17M
Total Cash (Recent Filing)$4.80M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.17
Next Earnings
Nov 18, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.70
Shares Outstanding14,677,000
10 Day Avg. Volume151,545
30 Day Avg. Volume202,258
Standard Deviation0.77
R-Squared0.00407
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)1.83
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.84
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NanoViricides News
Ownership Overview
―
Insiders
4.80% Mutual Funds
1.20% Other Institutional Investors
90.37% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
NNVC FAQ
What was NanoViricides’s price range in the past 12 months?
NanoViricides lowest stock price was $1.00 and its highest was $3.59 in the past 12 months.
What is NanoViricides’s market cap?
Currently, no data Available
When is NanoViricides’s upcoming earnings report date?
NanoViricides’s upcoming earnings report date is Nov 18, 2024 which is in 17 days.
How were NanoViricides’s earnings last quarter?
NanoViricides released its earnings results on Feb 15, 2024. The company reported -$0.18 earnings per share for the quarter, beating the consensus estimate of -$0.19 by $0.01.
Is NanoViricides overvalued?
According to Wall Street analysts NanoViricides’s price is currently Overvalued.
Does NanoViricides pay dividends?
NanoViricides does not currently pay dividends.
What is NanoViricides’s EPS estimate?
NanoViricides’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NanoViricides have?
NanoViricides has 13,945,589 shares outstanding.
What happened to NanoViricides’s price movement after its last earnings report?
NanoViricides reported an EPS of -$0.18 in its last earnings report, beating expectations of -$0.19. Following the earnings report the stock price went up 1.709%.
Which hedge fund is a major shareholder of NanoViricides?
Currently, no hedge funds are holding shares in NNVC
---
NanoViricides Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
NNVC Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 0.9%
Last 30 Days ▲ 0.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
26.54%
12-Months-Change
Fundamentals
Return on Equity
-63.00%
Trailing 12-Months
Asset Growth
-24.12%
Trailing 12-Months
Company Description
NanoViricides
NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.
---
Technical Analysis
---